We invest at the intersection of Biology and Deep Tech (ergo BioSoft)
In our view, just as it happened in the dot.com era, the current financial winter will bring the best vintages in startups, not seen in several decades. Most start-ups will disappear but the ones that thrive will define every major industry and become part of everyday life.
Our goal is to identify category leaders in the spaces that combine computational and life sciences. We back up early-stage startups, and once they’ve reached MVP (Minimum Viable Product), we support them in their journey from prototype to product by introducing them to a soft-landing program built to boost scaling capabilities in a cost-efficient environment. Achieving scale is a fundamental part of making a technology widespread and a startup successful. A key contribution we make to our startups is helping them with this endeavor.
Actual macro-conditions demand a lean, flexible and cost-efficient mindset to succeed, especially in the Biosoft space. We bring the necessary tools for startups to embrace this way of thinking and executing, without out-of-this-world investment rounds.
A key stone for this model is geographic location. Mexico is an optimal geography to SCALE as it sits a few hours south of the US, it has relevant free-trade agreements with multiple countries such as USMCA (TMEC)with the US in place and it exports more products to the US than all the rest of central and Latin America combined. It also has the necessary human talent at the right labor rate which is why it has become the biggest automotive hub in the world, hosting companies from Tesla to BMW.
Biology is the most advanced manufacturing technology on the planet. Just like software—or because of it—biology will one day become part of every industry.
Information technologies are now being applied to biosciences as well as almost every other human activity. Improvements in big data analysis are ing more and more information about systems and complex processes, creating incredible investment opportunities for entrepreneurs who can now harness data-driven technologies such as Artificial Intelligence or the Internet of Things.
Machine learning is a method of data analysis that automates analytical model building. It is a branch of artificial intelligence based on the idea that systems can learn from data, identify patterns and make decisions with minimal human intervention. AI will be applied in Computational Bio.
5G has the potential to enable fundamentally new applications and dramatically improve quality of life around the world via use cases that require instantaneous communications, low latency, and massive connectivity applications like mobile, eHealth, autonomous vehicles, smart cities, smart homes and the IoT.
Fintech aims to compete with traditional financial methods in the delivery of financial services. Big tech has the scale, data, and AI to win in key financial services verticals having billions of users and the power to keep those users engaged. They also have the AI and machine learning capabilities to make sense of all the data generated by their user bases.
BioFab technologies will rely on Smart IT to scale and become mainstream.
The 5th industrial revolution will come from nature.
Exponential Technologies are those which are rapidly accelerating and shaping major industries and all aspects of our lives. They include artificial intelligence, augmented and virtual reality, data science, digital biology and biotech, medicine, nanotech and digital fabrication, networks and computing systems, robotics, and autonomous vehicles among others.
We believe solutions to the world’s most pressing challenges lie at the intersection of these technologies. When two or more are combined to attack a persistent challenge, the possibility of developing a sustainable solution becomes much more likely.
With that in mind and after a long research and networking, we decided that the state of Guanajuato, Mexico, is the best option for Lantana BioSoft headquarters. More than 500 mulitnational companies have selected the state as their preferred destination for doing business in the last ten years.
Over the years the state has been characterized as a farming, food industry & biotechnology state, as well as an automotive manufacturing cluster. It has a very significant amount of biotech Ph. D.s and graduates, research labs, universities and startups.
For many years now, the icon of entrepreneurism and great technological success is made and forged in Silicon Valley. The team at Lantana BioSoft had built over many years relationships in Silicon Valley which represent a competitive advantage over other funds and asset classes. Likewise, the management team has alliances with successful Silicon Valley funds and accelerators coinvesting with them and becoming an M&A facilitator among Startups in the same space in both markets.
We have more than 20 years of experience investing in tech companies both in Mexico and Silicon Valley which gives us the experience and understanding of how Startups work, what are the challenges they face and how to accelerate their growth.
We invest on a thematic basis into industries that have multi-billion potential. Our investments are structured around the pace that start-ups evolve in terms of five-to-ten year development cycles. We search for Startups in comparable markets in Mexico and USA, preferably at the intersection of BioFab and Smart IT.